Flamel Technologies makes changes to its board
This article was originally published in Scrip
Drug delivery company Flamel Technologies has nominated three members to its board of directors: Dr Catherine Bréchignac, Guillaume Cerutti and the Honourable Craig Stapleton. Dr Bréchignac serves as the French Ambassador for science, technology and innovation, and has previously served as a board member of Renault SA. Mr Cerutti is the chairman and CEO of Sotheby's France, as well as a director of Ingenico SA. Ambassador Stapleton was US Ambassador to France from 2005 until 2009 and has served on the board of directors for several companies including Allegheny Properties and Winston Partners.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.